Chapter 36: Review of Hemodynamics

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Imagine pumping the entire fluid volume of a human body through a space roughly the size of a fist.

Yeah, and doing that every single minute of every single day.

Right, without a single pressure failure.

I mean, we expect precision in medicine, you know, a broken bone on an x -ray, it's static, you see the fracture, you cast it.

Exactly.

But stepping into cardiovascular pharmacology means basically abandoning that static blueprint entirely.

You're dealing with this dynamic, constantly shifting fluid system.

It's all governed by pressure gradients and electrical impulses.

And chemical reflexes too, right?

You're managing a live hydraulic network.

And if you're prescribing a drug to alter that network, you are instantly fighting the body's deeply ingrained survival mechanisms.

Which is exactly why you, as a Clintonal student or a practitioner gearing up for boards,

really need this material.

So today we're doing a deep dive into chapter 43 of Len's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants.

The third edition specifically.

Right, third edition.

And the core focus here is hemodynamics.

So, you know, the study of blood movement and all the regulatory forces driving it.

We aren't just reviewing anatomy today.

No, definitely not.

We're looking at the exact order of operations the body uses to maintain perfusion.

Yeah.

Because, I mean, you cannot safely dose a venodilator or an ACE inhibitor without understanding the exact physiological dominoes you're about to knock over.

You really can't.

The foundational logic for rational drug selection, it starts right here.

The underlying path of physiology dictates your therapeutic goals.

And then those goals drive your drug selection, which supports your dosing, your monitoring, and patient education.

If you understand the hemodynamics under the hood, you don't have to just blindly memorize adverse effects.

Because you can actually anticipate them.

Exactly.

So let's get right into the geography of the circulatory system.

Because the distribution of blood in a typical adult, it completely defies intuition.

It really does.

Yeah.

So the average adult has about five liters of total blood volume.

Intuitively, I think we all picture most of that blood just rushing through the arteries, powering the organs.

Like a high -speed transit system.

Exactly.

Yeah.

But the textbook shows this drastically lopsided reality.

So only 9 % is in the pulmonary circulation.

Right.

In the lungs.

And the heart itself holds about 7%.

So the vast majority, 84%, is out in the systemic circulation.

But the critical distinction within that 84 % is where it's actually residing.

Because it is not in the arterial system.

Yeah, that blew my mind.

Only 13 % is in the arteries.

And 7 % is in the arterials and capillaries.

Which means a staggering 64 % of our blood is just sitting in the veins, venules, and venous sinuses.

It's not rushing anywhere.

Right.

Just hanging out in this massive venous reservoir.

And this distribution, it's totally dictated by structural biology.

Arteries have a thick tunica media, dense, smooth muscle.

Because they have to withstand the immense ejection pressure of the left ventricle.

Exactly.

They are rigid.

But veins, they have significantly less smooth muscle in their walls.

They are like 6 to 10 times more distensible than arteries.

So they are super stretchy.

Kind of like if arteries are rigid,

high pressure fire hoses, then veins are basically highly expandable water balloons.

That is a perfect analogy.

So even a tiny increase in venous pressure causes a massive expansion of the vessel's diameter.

They just stretch and accommodate the extra volume.

Which immediately reframes how we look at specific drug classes, doesn't it?

Oh, absolutely.

Like when you prescribe a drug that targets vascular smooth muscle to cause venodilation, you aren't just slightly widening a pipe to improve flow.

No, you are massively expanding the botter's primary holding tank.

You're pooling fluid away from the heart.

Right.

And this brings us right to the fundamental physics of blood flow.

Blood flows strictly down a pressure gradient, right?

From higher pressure to lower pressure.

Always.

And pharmacologically, the primary determinant of resistance to that flow is vessel diameter.

I mean, we can't change the length of a patient's vessel.

No, obviously not.

And altering blood viscosity, that's a slow process.

But adjusting vessel diameter through medication, that happens in seconds.

And the pressure drop across the system is just extreme.

I mean, blood leaves the aorta at roughly 120 millimeters of mercury.

But by the time it hits the capillaries, friction and branching have dropped that pressure down to 30.

Significant drop.

Yeah.

And then leaving the capillaries and entering the venules, it's down to 18.

And by the time that blood travels all the way back to the right atrium of the heart, the pressure is actually zero.

Or even slightly negative, down to like negative five millimeters of mercury.

Right.

And Lanes explains that this negative right atrial pressure is largely a product of respiratory mechanics.

When you inhale, the expansion of the chest cavity creates negative intra -thoracic pressure.

Yeah, which steepens the gradient.

But the textbook refers to this negative pressure as creating a suction effect.

And I kind of push back on the implications of that word.

How so?

Well, the right atrium isn't functioning like, I don't know, a motorized vacuum cleaner actively sucking blood up from the toes.

Oh, right, right.

No, it's not a vacuum.

It's simply steepening the pressure gradient.

Blood at a pressure of 18 in the venules naturally falls toward a pressure of zero or negative five in the atrium.

The physics of the gradient does the work.

But you're right to question the sheer force of it, because a gradient of 18 down to zero, that's not nearly enough hydrostatic force to push fluid up a pair of legs against gravity.

Not when a patient is standing up, no.

So the body relies on two other mechanisms to ensure venous return.

First, venous smooth muscle constriction.

Even though veins are thin, they do have smooth muscle innervated by the sympathetic nervous system.

So constricting them slightly raises the pressure, nudging the blood forward.

Exactly.

And the second much more vital mechanism against gravity is the skeletal muscle pump.

Oh, with the valves.

Right.

The veins in the extremities are equipped with one -way bicuspid valves.

Every time skeletal muscles contract, like when you walk, they physically compress the deep veins.

So the blood is squeezed.

Squeezed, yeah.

And because the valves prevent backflow, it shoots upward toward the heart.

So if that skeletal muscle pump is inactive, say a patient is bedridden or, you know, on a really long haul flight.

The blood just pools in that highly distensible venous reservoir.

Which vastly increases the risk of deep vein thrombosis.

But assuming normal function, the right atrial pressure gradient, venous constriction, and the muscle pump all work together to dictate venous return.

And venous return dictates what the heart does next.

Because the heart can only pump what it receives.

Which brings us to cardiac output.

So cardiac output, the volume of blood pumped per minute, is just heart rate multiplied by stroke volume.

And that is entirely dependent on this venous return.

Completely.

Now, since you as a clinician listening to this are already familiar with the basics of preload and afterload, we can kind of bypass the dictionary definitions.

Yeah, we know preload is the stretch driven by venous return and afterload is the resistance.

I always picture it like a slingshot.

Preload is how far back you pull the rubber band, so the stretch.

And afterload is the thickness of the material you're trying to shoot through, with the resistance.

That's a great physical analogy.

And what Lenz really highlights here is the cellular mechanism underlying the Starling law of the heart.

We know that increased preload causes the heart to contract harder.

But why?

Yeah, looking at the sarcomere level.

Right.

Why does stretching the cardiac muscle fiber increase its contractile force?

It comes down to the spatial orientation of the contractile proteins,

actin and myosin.

In a resting sort of underfilled state,

the actin and myosin filaments are overlapped too much.

They basically interfere with each other.

Oh, I see.

But when venous return increases and stretches the ventricular wall, it pulls those sarcomeres into an optimal length.

The actin and myosin align perfectly, allowing the maximum number of cross bridges to form.

So more cross bridges mean a significantly more forceful contraction.

Exactly.

It's a remarkably elegant autoregulatory system.

The heart automatically adjusts its output to match the venous return, literally beat by beat.

But the stakes of this mechanism failing are honestly terrifying.

Especially when we look at the balance between the right and left ventricles.

Oh, the parity.

Yeah.

The right ventricle pumps to the lungs.

The left pumps to the systemic circulation.

And they must maintain perfect parity,

the exact same output.

Because the margin for error is essentially zero, let's trace a slight left ventricular impairment.

Say the right ventricle is pumping its normal five liters per minute into the pulmonary circulation.

But the left ventricle, perhaps due to like ischemic damage, loses just 1 % of its efficiency.

Just 1%.

So it pumps 4 .95 liters per minute out to the body.

Right.

Now a 1 % deficit seems totally negligible on a single beat.

Yeah, it sounds like nothing.

But over time, the math becomes lethal.

That means 50 milliliters of blood is left behind in the pulmonary circulation every single minute.

Oh, wow.

So in 20 minutes.

In 20 minutes, an entire liter of fluid has shifted from the systemic circulation and backed up into the lungs.

And in under 40 minutes, the patient is basically drowning in their own fluid, facing fatal pulmonary edema.

Exactly.

This is why recognizing left -sided heart failure symptoms early is a critical clinical priority.

Because the starling mechanism normally prevents this, right?

By ensuring the left ventricle stretches and compensates.

Yes.

But when a disease state breaks the starling curve, when the muscle is stretched way beyond its optimal length and actin and myosin can no longer grip, the compensatory mechanism just fails.

So the heart is at the mercy of its preload and afterload.

But the body isn't passive here.

It actively defends arterial pressure, which is, again, simply peripheral resistance multiplied by cardiac output.

Defends it aggressively.

If pressure drops or spikes, the body escalates its defense through three distinct systems operating on entirely different timelines.

The rapid response is the autonomic nervous system, specifically the baroreceptor reflex.

This system adjusts pressure in a matter of seconds.

The baroreceptors are those stretch receptors located in the aortic arch in the carotid sinus, right?

Right.

And they are constantly firing afferent signals up cranial nerves, IX and X, straight to the medullary cardiovascular center in the brainstem.

So if arterial pressure drops, the vessel walls stretch less, so the baroreceptors fire less frequently, and the medulla interprets this as an emergency.

Instant panic mode.

Yeah, it immediately increases sympathetic outflow and decreases parasympathetic vagal tone.

And the physiological result is instant.

The eszynode fires faster to increase heart rate, ventricular muscle increases its contractility, arterioles constrict to raise peripheral resistance, and veins constrict to boost venous return.

But the clinical catch with the baroreceptor reflex, and this is a massive hurdle in pharmacology, is that it's designed to fight acute changes, not chronic ones.

Exactly.

If pressure stays high for a day or two, the baroreceptors adapt.

They just accept the new elevated pressure as the baseline normal and stop trying to lower it.

It is an evolutionary mechanism designed for sudden posture changes or, you know, acute hemorrhage, not for managing decades of essential hypertension.

No, definitely not.

I like to think of it like olfactory adaptation, but for hemodynamics.

Olfactory adaptation.

Yeah, like nose blindness.

You walk into a pungent room and it's totally overwhelming, but an hour later, your receptors just accept it as normal.

That's actually, that's exactly what happens.

And because the baroreceptors reset, we run into a major issue when introducing vasodilators.

If you prescribe a drug that rapidly dilates the arterioles to drop dangerous blood pressure.

The baroreceptors, which had accepted the high pressure as normal, immediately sense the drop and panic.

Right.

They trigger reflex tachycardia.

The heart races to fight the exact therapeutic effect you're trying to achieve.

Which dictates a very specific clinical reasoning framework.

You cannot just prescribe a potent, direct -acting vasodilator in a vacuum.

You must anticipate the reflex tachycardia.

Right.

So you often co -administer a beta blocker to suppress sympathetic stimulation to the heart.

Exactly.

You are using one drug to achieve the goal and another to prevent the body's rapid response sabotage.

So since the baroreceptors adapt so quickly, the body obviously requires a slower, sustained system to manage pressure over hours and days.

And that brings us to the RAAS, the renin angiotensin aldosterone system.

We shift from fast electrical reflexes to a slower chemical cascade.

Right.

And the trigger here is reduced renal blood flow.

When arterial pressure drops, juxtalomerular cells in the kidneys release the enzyme renin.

Renin then converts angiotensinogen into angiotensin I, which is then converted by ACE into angiotensin II.

And angiotensin II is like one of the most potent vasoconstrictors in the human body.

Incredibly potent.

But it doesn't just clamp down on the arterials.

It triggers the adrenal cortex to release aldosterone.

And the mechanism of aldosterone is what truly sustains the pressure.

Because it acts on the distal tubules of the nephrons to upregulate epithelial sodium channels.

By actively reabsorbing sodium, water follows osmotically back into the bloodstream, increasing total blood volume.

And over an even longer timeline, like days to weeks, the kidneys exert independent control.

Low arterial pressure simply drops the glomerular filtration rate.

So less fluid is filtered into the renal tubules, meaning less urine is produced, and more water is retained in the systemic circulation.

Exactly.

So we have the baroreceptors firing electrical panic signals in seconds, the RAAS deploying vasoconstrictors and sodium retainers over hours, and the kidneys clamping down on filtration over days.

All of these systems are designed to raise pressure and retain volume.

Which raises the question, what is the physiological countermeasure?

I mean, if a patient is volume overloaded, how does the body defend against hypervolemia?

The counter -regulatory system relies on the natriuretic peptides.

There are three primary types.

Atrial natriuretic peptide, or ANP, is synthesized by the myocytes of the atria.

Grain natriuretic peptide, BNP, is produced by the ventricles, actually, despite its name.

Right, brain natriuretic peptide from the ventricles.

Yes.

Classic medical naming.

I know, right?

And C -tach natriuretic peptide, CNP, is produced by the vascular endothelium.

So if the heart gets stretched beyond normal physiological limits by excess volume, the myocytes release ANP and BNP.

Yes.

And these peptides bind to specific receptors on vascular smooth muscle and renal cells, which increases intracellular CGMP.

This has three massive effects that directly oppose the RAAS and sympathetic system.

That's okay, what's the first?

First, they trigger profound diuresis and natriuresis.

They directly inhibit sodium reabsorption in the collecting ducts, forcing the kidneys to excrete sodium and water.

Wow.

Second, they cause vasodilation, dropping both preload and afterload.

And third, they increase vascular permeability, allowing fluid to shift out of the intravascular space.

So they're essentially the body's endogenous volume reduction system.

Exactly.

And clinically, BNP levels are a vital diagnostic marker.

If you see highly elevated BNP on a lab panel, it is a direct biochemical cry for help from ventricles that are stretched to their limits by volume overload.

That's such a great way to put it.

So we've established this incredibly complex, multi -layered regulatory environment.

You have venous pooling, pressure gradients, the Starling curve,

baroreceptors, RAAS and natriuretic peptides, all constantly adjusting.

It's a lot.

And the true test of a clinician's understanding is applying this interconnected system to real -world patient scenarios, particularly when administering medication.

Let's do that.

Let's apply it to a very common clinical occurrence that highlights literally every single concept we've discussed today, orthostatic or postural hypotension.

Perfect example.

So a patient is lying down, they stand up suddenly, and they feel incredibly dizzy.

The hemodynamics of that moment are drastic.

Gravity violently pulls the blood downward because the veins are highly distensible.

Remember the water balloons?

The blood just pools in the lower extremities.

Instantly, between 300 to 800 milliliters of blood pools in the legs.

It's just trapped in the venous reservoir, meaning venous return plummets.

And following Starling's law, preload drops, causing a severe drop in stroke volume.

Within a fraction of a second, just by standing up, cardiac output can drop by up to two liters per minute.

Which is massive.

But in a healthy, unmedicated state, the compensatory systems fire instantly.

Right, the skeletal muscle pump squeezes the veins.

The baroreceptors sense the drop in carotid pressure and trigger immediate tachycardia and venous constriction.

And blood flow to the brain is restored before the patient actually faints.

Yes.

But introduce a cardiovascular drug, and the entire safety net collapses.

Because if a patient is taking a systemic venodilator, or like an alpha adrenergic blocker that prevents venous constriction, the physiology changes.

They stand up.

Gravity pulls the blood, the baroreceptor reflex fires, triggering tachycardia.

But because the drug is blocking the veins from constricting, the blood cannot be pushed back up to the heart.

The heart is racing, but it's pumping empty.

Exactly.

The compensatory tachycardia is entirely ineffective because venous return hasn't been restored.

The drop in cerebral perfusion persists, and the patient experiences syncope.

They faint.

This is exactly why patient education is a paramount responsibility for advanced practice nurses and PAs.

If you are prescribing an alpha blocker or a venodilator, the black box warnings and safety alerts are not just administrative hurdles.

No, they are direct translations of this pathophysiology.

You must educate the patient on exactly why they need to move slowly from a supine to a standing position.

The education isn't just, hey, be careful standing up.

It is explaining that their medication intentionally disables the blood vessel's ability to fight gravity, meaning they have to give their body time to adjust through other means.

The underlying pathophysiology supports the therapeutic goal, and understanding the drugs mechanism ensures a safe, patient -centered outcome.

Well said.

So we started this session by looking at the circulatory system as a live hydraulic network.

We traced the massive suid reservoirs just hanging out in the venous system.

We examined how the right atrium's pressure gradient and the skeletal muscle pump fight gravity to maintain that venous return.

Right.

We looked under the hood of the starling mechanism, seeing how actin and myosin alignment perfectly balances pulmonary and systemic output, and we watched the escalating war between the marrow receptors,

the RAS cascade, and the natriuretic peptides.

All working to maintain perfusion without overloading the pump.

It is a delicate, elegant system.

It really is.

But as a clinician,

your pharmacological interventions are, frankly,

a blunt instrument entering a finely tuned environment.

Which leaves me with a final, somewhat provocative thought for you to carry forward into your clinical rotations.

We spend an enormous amount of time and pharmacological effort fighting the downstream effects of this system, right?

Forcing vessels open, forcing kidneys to dump water, blocking receptors.

Yeah, constant fighting.

But if the baroreceptors in the carotid sinus literally reset and accept hypertension as the new normal after a couple of days,

what if the future of cardiovascular medicine isn't about fighting fluid dynamics at all?

Oh, interesting.

What if research eventually allows us to physically or chemically recalibrate the stretch receptors themselves?

Like simply reprogramming the body's thermostat to its factory settings?

That is exactly the kind of systems -level thinking that pushes pharmacology forward.

Right.

Something to think about.

Well, from all of us on the Last Minute Lecture team, thank you for joining us.

We hope this deep dive clarified the hemodynamics chapter and gave you the physiological framework you need for rational drug selection.

Keep studying the underlying mechanisms, keep anticipating the adverse effects.

And we will catch you on the next deep dive.